These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency. Frampton JE Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737 [TBL] [Abstract][Full Text] [Related]
6. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency. Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368 [TBL] [Abstract][Full Text] [Related]
7. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency. Ezgü F Expert Opin Drug Saf; 2022 Feb; 21(2):149-155. PubMed ID: 34664536 [TBL] [Abstract][Full Text] [Related]
8. Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D). Aigner E; Feldman A; Neureiter D; Datz C; Ratziu V; Paulweber B Am J Gastroenterol; 2018 Mar; 113(3):443-445. PubMed ID: 29535442 [No Abstract] [Full Text] [Related]
9. Sebelipase alfa: first global approval. Shirley M Drugs; 2015 Nov; 75(16):1935-40. PubMed ID: 26452566 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis. Baronio F; Conti F; Miniaci A; Carfagnini F; Di Natale V; Di Donato G; Testi M; Totaro C; De Fanti A; Boenzi S; Dionisi-Vici C; Esposito S; Pession A Mol Genet Metab Rep; 2022 Mar; 30():100833. PubMed ID: 35242567 [TBL] [Abstract][Full Text] [Related]
12. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study. Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639 [TBL] [Abstract][Full Text] [Related]
13. Lysosomal Acid Lipase Deficiency in Japan: A Case Report of Siblings and a Literature Review of Cases in Japan. Ikari N; Shimizu A; Asano T J Nippon Med Sch; 2018; 85(2):131-137. PubMed ID: 29731497 [TBL] [Abstract][Full Text] [Related]
14. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251 [TBL] [Abstract][Full Text] [Related]
18. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy. Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531 [TBL] [Abstract][Full Text] [Related]
19. A Novel Mutation c.153 C>A in a Tunisian Girl With Wolman Disease and Unusual Presentation: Hemophagocytic Lymphohistiocytosis. Tinsa F; Ben Romdhane M; Boudabous H; Bel Hadj I; Brini I; Tebib N; Louati H; Bekri S; Boussetta K J Pediatr Hematol Oncol; 2019 Apr; 41(3):e193-e196. PubMed ID: 29702543 [TBL] [Abstract][Full Text] [Related]
20. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency. Valayannopoulos V; Malinova V; Honzík T; Balwani M; Breen C; Deegan PB; Enns GM; Jones SA; Kane JP; Stock EO; Tripuraneni R; Eckert S; Schneider E; Hamilton G; Middleton MS; Sirlin C; Kessler B; Bourdon C; Boyadjiev SA; Sharma R; Twelves C; Whitley CB; Quinn AG J Hepatol; 2014 Nov; 61(5):1135-42. PubMed ID: 24993530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]